Eye-catching pharma firms
Ex-Japan Asia's pharmaceutical industry is largely polarised between the low-cost generics drug-makers of India and the fragmented market that serves Korea's aging population. Global trends and rising costs translate into steady growth, but at the same time add to the pressure to consolidate. Chris Wright measures out the sector's top 10 regional companies in terms of return on equity.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts